Treatment responses and mechanisms of hypomethylating agents in patients with acute myeloid leukemia
碩士 === 國立臺灣大學 === 臨床醫學研究所 === 106 === Acute myeloid leukemia (AML) is defined as myeloblast more than 20% in either peripheral blood or bone marrow. The prognosis for acute myeloid leukemia (AML) patients who are unfit or refractory to chemotherapy is dismal. Hypomethylating agents (HMA), azacitidin...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/9t7wfv |